Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1790 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
RATIO-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-03-14 | 2020-02-13 | 2419 |
TEVA-TERBINAFINE | 250MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1655 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1697 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1711 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1691 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-02-21 | 98179 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-01-09 | 2020-02-21 | 102893 |
TEVA-TOPISONE | .05% | CREAM | Resolved | 2020-01-24 | 2020-02-21 | 104362 |
TEVA-COTRIDIN | 30MG 2MG 10MG | SYRUP | Resolved | 2020-01-30 | 2020-02-21 | 104911 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-02-13 | 2020-02-21 | 106012 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99971 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |